Susquehanna International Group, LLP Abeona Therapeutics Inc. Put Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.12 - $6.32 $38,728 - $59,408	9,400 Added 53.41%	27,000 $170,000
Q2 2024 Aug 15, 2024	BUY	$3.17 - $8.05 $12,997 - $33,005	4,100 Added 30.37%	17,600 $74,000
Q1 2024 May 07, 2024	SELL	$4.07 - $8.68 $89,947 - $191,828	-22,100 Reduced 62.08%	13,500 $97,000
Q4 2023 Feb 14, 2024	BUY	$3.71 - $5.14 $132,076 - $182,984	35,600 New	35,600 $178,000

26.9M

614K

45K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $33.1M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.